atDose Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
2
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
6
atDose General Information
Description
Developer of a mobile dosing and infusion device designed to change the treatment methods for serious illnesses. The company's device directly administers the drug to the affected area by combining a microneedle and an electroosmotic flow pump as used in acupuncture and moxibustion treatment, enabling cancer patients to reduce their physical burden, which is caused by the side effects of drugs.
Contact Information
Website
atdose.comCorporate Office
- Asahi Ward
- Yokohama, Kanagawa
- Japan
Corporate Office
- Asahi Ward
- Yokohama, Kanagawa
- Japan
atDose Timeline
atDose Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Accelerator/Incubator | 19-Jan-2026 | Completed | Generating Revenue | |||
| 8. Equity Crowdfunding | 19-Nov-2025 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series A) | 24-Dec-2024 | Completed | Generating Revenue | |||
| 6. Equity Crowdfunding | 18-Jun-2024 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 04-Nov-2021 | Completed | Generating Revenue | |||
| 4. Seed Round | 31-Aug-2021 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 01-Sep-2020 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 1. Accelerator/Incubator | 01-Jan-2018 | Completed | Generating Revenue |
atDose Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Ordinary |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
atDose Patents
atDose Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-7881149-B1 | Electroosmotic flow pumps and liquid transfer devices | Active | 20-Apr-2026 | ||
| JP-2025168615-A | Electric syringe | Pending | 29-Apr-2024 | ||
| JP-7324555-B1 | Manufacturing method of syringe and integrated plunger | Active | 20-Feb-2023 | ||
| WO-2024176821-A1 | Syringe | Inactive | 20-Feb-2023 | ||
| JP-2024118395-A | Syringe and manufacturing method of integral pusher | Active | 20-Feb-2023 |
atDose Signals
atDose Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Japan External Trade Organization | Accelerator/Incubator | |||
| J-StarX | Accelerator/Incubator | |||
| DEFTA Partners | Venture Capital | Minority | ||
| FASTAR | Accelerator/Incubator | |||
| Kawasaki Deep Tech Accelerator | Accelerator/Incubator |
atDose FAQs
-
When was atDose founded?
atDose was founded in 2017.
-
Where is atDose headquartered?
atDose is headquartered in Yokohama, Japan.
-
What is the size of atDose?
atDose has 2 total employees.
-
What industry is atDose in?
atDose’s primary industry is Medical Supplies.
-
Is atDose a private or public company?
atDose is a Private company.
-
What is atDose’s current revenue?
The current revenue for atDose is .
-
How much funding has atDose raised over time?
atDose has raised $4.53M.
-
Who are atDose’s investors?
Japan External Trade Organization, J-StarX, DEFTA Partners, FASTAR, and Kawasaki Deep Tech Accelerator are 5 of 6 investors who have invested in atDose.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process